StockMarketWire.com - Cell-based therapy company MaxCyte said it would make to presentations to a key industry conference in London.

The presentations would be made to the Annual Cell & Gene Therapy Congress taking place 29-30 October and display the company's technology.


At 9:11am: [LON:MXCT] MaxCyte Inc share price was 0p at 117.5p



Story provided by StockMarketWire.com